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Essential Role for the dsRNA-Dependent
Protein Kinase PKR in Innate
Immunity to Viral Infection
or the key signaling molecule STAT1 have been shown
to be extremely sensitive to infection with a number of
viruses, including vesicular stomatitis virus (VSV), en-
cephalomyocarditis virus (EMCV), and various strains of
influenza virus (Muller et al., 1994; Durbin et al., 1996;
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the IFN-responsive genes accountable for these actionsWayne State University
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proteins exhibiting antiviral activity include the 2±5(A)§Department of Pediatrics
synthetase/RNase L enzymes and the Mx family, thesekEmory University
proteins only appear to influence the regulation of cer-Atlanta, Georgia 30322
tain classes of virus, emphasizing that different antiviral
mechanisms may be mediated by a diverse array of IFN-
induced proteins (Stark et al., 1998).Summary
The double-stranded (ds) RNA-dependent serine/
threonine protein kinase PKR is another IFN-inducibleThe double-stranded (ds) RNA-dependent protein ki-
gene that has been proposed to play a role in antiviralnase PKR is considered to play an important role in
host defense (Meurs et al., 1990). PKR is constitutivelyinterferon's (IFN's) response to viral infection. Here,
expressed in the absence of IFN induction and existswe demonstrate that mice lacking PKR are predis-
as a latent 68 kDa or 65 kDa molecule in human andposed to lethal intranasal infection by the usually in-
murine cells, respectively. Following interaction withnocuous vesicular stomatitis virus, and also display
dsRNA, PKR autophosphorylates and, in turn, phos-increased susceptibility to influenza virus infection.
phorylates substrate targets, the best characterized be-Our data indicate that in normal cells, PKR primarily
ing the a subunit of eukaryotic protein synthesis initia-prevents virus replication by inhibiting the translation
tion factor 2 (eIF2a) (Panniers and Henshaw, 1983).of viral mRNAs through phosphorylation of eIF2a,
Phosphorylation of eIF2a on serine 51 causes a dramaticwhile concomitantly assisting in the production of au-
inhibition of protein synthesis in the cell by sequesteringtocrine IFN and the establishment of an antiviral state.
the guanine nucleotide exchange factor eIF2B, a rate-These results show that PKR is an essential compo-
limiting component of the translation machinery. Se-nent of innate immunity that acts early in host defense
questered eIF2B prevents the exchange of GDP for GTPprior to the onset of IFN counteraction and the ac-
on eIF2a and inhibits the initiation of protein synthesisquired immune response.
(Hershey, 1991). In addition to this role, PKR has also
been reported to function in a variety of signaling path-Introduction
ways, including those involving dsRNA, PDGF, and NF-
kB (Mundschau and Faller, 1995; Yang et al., 1995; DerThe interferons (IFNs) are a family of related pleiotropic
et al., 1997; Kumar et al., 1997; Chu et al., 1999). Recentcytokines with potent antiviral, immunomodulatory, and
evidence from our group and others have also demon-antiproliferative activities that exert their multiple effects
strated that activation of PKR can induce the expression
through the induction of .30 responsive genes (Stark
of Fas and trigger apoptosis through the FADD/cas-
et al., 1998). The IFNs are classified into two major cate-
pase-8 death signaling pathway (Balachandran et al.,
gories referred to as type I (a, b) and type II (g). Type I 1998; Donze et al., 1999). In contrast, overexpression of
IFNs are induced by most cell types in response to a catalytically inactive PKR variant renders immortalized
viruses or double-stranded (ds) RNA, while type II IFN cells resistant to a number of apoptotic stimuli and in-
is mainly expressed by activated T lymphocytes and duces their malignant transformation (Koromilas et al.,
natural killer cells in response to various growth factors 1992; Meurs et al., 1990; Balachandran et al., 1998).
and cytokines (Sen and Ransohoff, 1998). Following ex- Unsurprisingly, to neutralize the deleterious effects that
pression, the IFN proteins are secreted, bind to species- activation of PKR would have upon viral replication, nu-
specific cell surface receptors, and trigger the transcrip- merous viruses, including vaccinia virus, adenovirus,
tion of genes through activation of Jak-STAT signaling hepatitis C, and human immunodeficiency virus type I,
pathways (Darnell et al., 1994). appear to have developed strategies to suppress this
The importance of IFN in antiviral host defense has kinase (Katze, 1993).
been demonstrated by a number of methods, most nota- Despite a plethora of evidence implicating a role for
bly through the use of genetically engineered mice that PKR in host defense, mice with targeted disruptions in
lack key components of the IFN-signaling pathway. For the PKR gene have not yet been reported to exhibit any
example, mice lacking functional type I IFN receptors significant defect in immunity to viral infection. Although
the antiviral effects of IFN-g against EMCV infection
were reportedly impaired, host responses to a number#To whom correspondence should be addressed (e-mail: gbarber@
med.miami.edu). of viruses including vaccinia virus were described as
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normal (Yang et al., 1995; Abraham et al., 1999). Indeed,
mice doubly defective in both PKR and RNase L showed
only partial defects in response to EMCV infection (Zhou
et al., 1999). Although these data highlight possible re-
dundancies in the IFN antiviral system and accentuate
the existence of alternate key antiviral genes, it is plausi-
ble that the type of virus, route of infection, and even
genetic strain of the host complicates the evaluation of
genes considered important in host defense.
Taking this into consideration, we have extended the
evaluation of PKR's role in innate immunity to viral infec-
tion. Our data indicate that PKR-deficient mice but not
wild-type mice are extremely susceptible to lethal VSV
and influenza virus (WSN) infection. We further show
that PKR inhibits VSV replication at the level of viral
translation by phosphorylating eIF2a, while assisting
with autocrine IFN production. Although IFN treatment
of fibroblasts lacking PKR could prevent VSV replication
in vitro, these cytokines could not protect PKR2/2 mice
from fatal intranasal infection, further suggesting an in-
operative IFN system in certain tissues of the respiratory
tract. PKR's ability to encumber viral replication is thus
nonredundant and likely allows time for the acquired
arm of host immunity to respond to and assist in the
eradication of the infectious agent.
Results
PKR-Deficient Fibroblasts Contain Low Levels
of Phosphorylated eIF2a
To further characterize cells deficient in PKR, primary
embryonic fibroblasts (EFs) obtained from mice con-
taining a deletion in the catalytic domain of PKR (Abra-
ham et al., 1999) were treated with or without dsRNA
[poly (I:C)] in the presence or absence of mIFN (a/b) and
were analyzed for PKR protein expression and kinase
activity. As shown in Figure 1, an increase in PKR ex-
pression was observed in wild-type EFs treated with Figure 1. Ablation of PKR in EFs from Mice with a Targeted Disrup-
tion of the Catalytic Domain of PKRIFN (Figure 1A, compare lane 2 to lane 1). In vivo [32P]or-
(A) EFs from PKR1/1 (lanes 1±3) and PKR2/2 (lanes 4±6) mice werethophosphate labeling experiments also showed an in-
left untreated (lanes 1 and 4), treated with murine interferon (mIFN-crease in PKR phosphorylation levels following dsRNA
a/b) alone for 18 hr (lanes 2 and 5), or pretreated with mIFN for 18treatment (Figure 1B, compare lane 3 to lane 2). Impor-
hr and subsequently transfected with poly (I:C) (lanes 3 and 6).
tantly, we were unable to detect PKR protein expression Lysates prepared from these cells were analyzed by Western blot-
or kinase activity in EFs derived from PKR2/2 mice (Fig- ting for the presence of murine PKR (mPKR) using an mPKR-specific
ures 1A and 1B, lanes 4±6). antibody.
(B) EFs from PKR1/1 and PKR2/2 mice treated as above were labeledWe next examined the phosphorylation status of
during the last 4 hr of their treatment with [32P]orthophosphate.eIF2a in PKR1/1 and PKR2/2 EFs using antibodies capa-
mPKR was precipitated from lysates prepared from these cells usingble of detecting either total or phosphorylated eIF2a
poly (I:C)±agarose beads and visualized by autoradiography follow-
protein. While the levels of total eIF2a were essentially ing SDS-PAGE.
equivalent in both types of fibroblasts, there was a sig- (C) PKR1/1 (lanes 1 and 2) and PKR2/2 (lanes 3 and 4) EFs were
nificant reduction but not complete ablation of phos- transfected with poly (I:C) (lanes 2 and 4) for 4 hr, or mock-trans-
fected (lanes 1 and 3), lysed, and analyzed by Western blotting forphorylated eIF2a in PKR2/2 EFs (Figure 1C, compare
phosphorylated eIF2a (a) or total eIF2a (b) using antibodies specificlane 3 to lane 1). DsRNA treatment did not appear to
for eIF2a phosphoserine 51, or total eIF2a, respectively. Identitiesaffect the levels of total eIF2a in EFs from PKR1/1 or
of the individual proteins are indicated on the right.
PKR2/2 mice but did cause an increase (almost 2-fold)
in the levels of phosphorylated eIF2a only in fibroblasts
from PKR1/1 mice (Figure 1C, compare lane 1 to lane mice were treated with or without mIFN-a/b or mIFN-g
2). These results demonstrate that PKR is a key regulator and subsequently infected with a selection of RNA vi-
of eIF2a in these cells. ruses including VSV. We observed that VSV infection at
a multiplicity of infection (moi) of 10 induced cytolysis
of PKR2/2 EFs with the morphological characteristics ofPKR2/2 Fibroblasts Are Susceptible to VSV
Replication and Caspase 9±Activated Apoptosis apoptosis by 18 hr postinfection (Figure 2A, panel e). In
contrast, PKR1/1 EFs remained mostly viable for at leastTo further evaluate the antiviral role of PKR, primary
embryonic fibroblasts obtained from PKR1/1 and PKR2/2 36 hr postinfection (Figure 2A, panel b). We also found
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Figure 2. VSV Induces Apoptosis in PKR2/2 Primary EFs
PKR1/1 (a±c) and PKR2/2 (d±f) EFs were treated with (c and f) or without (a, b, d, and e) mIFN-a/b for 18 hr and mock-infected (a and d) or
infected with VSV (Indiana strain) at an moi of 10 (b, c, e, and f). Twenty hours postinfection, cells were (A) photographed at 2003 magnification
or (B) analyzed for apoptosis using FITC-conjugated annexin V by flow cytometry and TUNEL (inset). Percent cells staining positive for annexin
V within the defined region are shown in each panel above the region bar.
that pretreatment with either mIFN-a/b or -g completely no increase in annexin V staining or evidence of DNA
fragmentation over mock-infected samples (15.75% in-protected the PKR2/2 EFs against VSV-induced cell
death, indicating that an IFN-induced component capa- fected versus 18.66% uninfected). Interestingly, IFN-
treated, VSV-infected PKR2/2 EFs were protected againstble of inhibiting VSV replication can compensate for the
loss of PKR in these cells (Figures 2A, panel f, and 3A). virus-induced apoptosis (Figure 2B). Similar results were
obtained when VSV infections were performed at an moiTo establish whether PKR2/2 EFs were indeed under-
going apoptosis following VSV infection, PKR1/1 and of 1 (data not shown).
We also examined the relative sensitivities of PKR1/1PKR2/2 cells infected as above were analyzed for
annexin V binding, an early indicator of apoptosis, as and PKR2/2 EFs to dsRNA-mediated apoptosis. We
found PKR2/2 EFs to be remarkably resistant to dsRNA-well as by TUNEL. As shown in Figure 2B, VSV-infected
PKR2/2 EFs displayed a marked increase in annexin V triggered cell death (z10% were dead 24 hr posttreat-
ment), while in contrast, z80% of the wild-type EFs werebinding (79.73% infected versus 13.47% uninfected) and
TUNEL staining, while VSV-infected PKR1/1 EFs showed dead within 24 hr of dsRNA transfection (Figure 3B).
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Figure 3. Differential Effects of PKR and IFN on VSV- and dsRNA-Induced Apoptosis in Primary EFs
(A) PKR1/1 and PKR2/2 EFs were infected with VSV in the presence or absence of either anti-mIFN-a/b neutralizing antibodies or 18 hr mIFN-
a/b or mIFN-g pretreatment. Cell viability was determined 24 hr postinfection by trypan blue exclusion.
(B) PKR1/1 and PKR2/2 EFs were transfected with poly (I:C) in the presence or absence of 18 hr mIFN-a/b or mIFN-g pretreatment. Twenty-
four hours posttransfection, cell viability was assayed by trypan blue exclusion. Data shown represent the mean 6 SD of triplicate samples
of one of two experiments with similar results.
(C) PKR1/1 and PKR2/2 EFs were transfected with poly (I:C) or infected with VSV (moi 5 10) and analyzed for caspase 8 or caspase 9 activity
24 hr posttreatment, as described in Experimental Procedures. Data shown represent the average of triplicate samples of one of two
independent experiments with similar results.
Since IFN has been reported to sensitize cells to dsRNA- wild-type EFs underwent rapid dsRNA-induced apo-
ptosis following IFN treatment, PKR2/2 EFs remainedinduced cytotoxicity (Stewart et al., 1972), we examined
whether priming with either mIFN-a/b or mIFN-g could mostly viable, indicating the essential role of PKR in
regulating IFN-mediated, dsRNA-induced apoptosis (Fig-render PKR2/2 EFs susceptible to dsRNA-induced apo-
ptosis. Accordingly, wild-type and PKR2/2 EFs were pre- ure 3B).
To evaluate the mechanisms of apoptosis further, wetreated with either IFN-a/b or IFN-g for 18 hr prior to
transfection with dsRNA. However, while virtually all the examined caspase 8 and 9 activity using fluorogenic
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action by preventing ligation to their receptors. Strik-Table 1. Viral Titers from PKR1/1 and PKR2/2 EFs in the
ingly, we found that neutralizing anti-IFN-a/b antibodyPresence of mIFN-a/b Pretreatment or in the Presence of
treatment rendered normal fibroblasts containing PKRNeutralizing Anti-mIFN-a/b Antibodies
susceptible to VSV replication and cell death (Table 1;Untreated mIFN-a/b Anti-mIFN-a/b
Figure 3A). In fact, viral yields from PKR1/1 cells treatedGenotype moi (pfu/ml) (pfu/ml) (pfu/ml)
with neutralizing anti-IFN-a/b antibodies had now in-
PKR1/1 1 1.4 3 103 3.5 3 102 2.5 3 106 creased into the range of those observed from PKR2/2
PKR1/1 10 4.8 3 103 4.7 3 102 2.4 3 107
cells in the absence of antibody treatment (Table 1).PKR2/2 1 6.4 3 107 3.5 3 104 8.8 3 108
Interestingly, PKR2/2 cells cultured in the presence ofPKR2/2 10 7.3 3 107 8.3 3 104 1.7 3 109
neutralizing anti-IFN-a/b antibodies after VSV infection
Numbers represent mean of duplicate samples from two indepen-
yielded 10-fold more virus than VSV-infected PKR2/2dent experiments. Individual titers did not vary by more than one
cells (Table 1). This suggests that VSV can induce somelog.
IFN in PKR2/2 cells able to modestly affect viral replica-
tion even in the absence of PKR. Nevertheless, these
data clearly demonstrate a nonredundant role for PKRtetrapeptide substrates specific for each caspase in a
in the IFN response to VSV infection and demonstratefluorometric assay. As we have previously shown in wild-
the synergistic nature of IFN and PKR in maintaining antype cells, dsRNA treatment results in the activation of
antiviral state in the cell.caspase 8 (Figure 3C; Balachandran et al., 2000). In
contrast, PKR2/2 EFs did not exhibit any significant in-
crease in caspase 8 activity following dsRNA treatment. PKR Inhibits VSV Protein Synthesis
In an attempt to analyze the mechanism by which PKROur data also show that VSV infection predominantly
causes the activation of caspase 9 rather than of cas- inhibits VSV replication, we infected PKR1/1 and PKR2/2
EFs with VSV in the presence of [32P]orthophosphatepase 8, and primarily in the PKR-deficient fibroblasts.
Thus, VSV induces apoptosis through a mechanism that and examined the in vivo phosphorylation status of PKR.
As seen in Figure 4A, PKR clearly becomes activatedappears different from that triggered by dsRNA, and
that proceeds, at least in part, through the activation of by VSV following infection of the cell (Figure 4A, compare
lanes 2 and 4 to lanes 1 and 3). However, as expected,caspase 9.
We next determined whether the induction of apo- no phosphorylated 65 kDa protein corresponding to
PKR can be seen in precipitates from PKR2/2 EFs fol-ptosis by VSV in PKR2/2 cells correlated with an in-
crease in viral replication. Virus progeny yield from lowing VSV infection and/or IFN treatment (Figure 4A,
lanes 5±8).PKR1/1 and PKR2/2 EFs previously treated with or with-
out mIFN-a/b and infected with VSV at an moi of 1 or VSV-infected PKR1/1 and PKR2/2 EFs were concomi-
tantly analyzed for PKR protein expression and levels10 were measured 36 hr postinfection. While PKR1/1
cells were found to be essentially nonpermissive to VSV of phosphorylated and unphosphorylated eIF2a. As
shown in figure 4B, IFN treatment caused a slight in-(Table 1, 1.4 3 103 pfu/ml virus yields at an moi of 1),
PKR2/2 cells proved quite capable of sustaining VSV crease in PKR protein levels in PKR1/1 EFs (panel a,
compare lanes 3 and 4 to lanes 1 and 2), although asreplication, and yields corresponding to 6 to 7 3 107
pfu/ml were routinely at an moi of 1 (Table 1). Although previously demonstrated, no PKR was detected in ly-
sates prepared from PKR2/2 EFs. Importantly, we alsoIFN pretreatment was able to significantly decrease vi-
rus yields from PKR2/2 EFs, these cytokines were not observed an increase in the level of phosphorylated
eIF2a in VSV-infected PKR1/1 EFs (Figure 4B, panel b,able to completely restore these cells to the nonpermis-
sive state seen in PKR1/1 EFs (Table 1, 3.5 3 104 pfu/ compare lanes 2 and 4 to lanes 1 and 3). This increase
was not seen in similarly treated PKR2/2 EFs (Figure 4B,ml yield from IFN-treated PKR2/2 EFs versus z3.5 3 102
pfu/ml from IFN-treated PKR1/1 EFs). panel b, compare lanes 6 and 8 to lanes 5 and 7). In
fact, a slight decrease in the amount of phosphorylated
eIF2a was observed in the VSV-infected PKR2/2 EFsIFN Produced during VSV Infection Is Required for
the Complete Protection of PKR1/1 Fibroblasts compared to the levels in mock-infected cells of the
same genotype. Equivalent levels of total eIF2a andIt is known that cells lacking a functioning IFN system,
such as IFN-a/b receptor- and STAT1-deficient EFs, are tubulin confirm that approximately equal amounts of
total protein are present in each lane (Figure 4B, panelsalso susceptible to VSV infection, even though PKR is
presumably present in these cells (Muller et al., 1994; c and d). These data clearly demonstrate that PKR is
activated and phosphorylates eIF2a during VSV infec-Durbin et al., 1996; Meraz et al., 1996). We therefore
speculated that PKR may function at an early step in tion. It is further interesting to note that although IFN
pretreatment was able to prevent VSV replication incellular antiviral defense, primarily to delay the transla-
tion of viral mRNAs and consequent virion production PKR-deficient fibroblasts, the absence of any increase
in eIF2a phosphorylation levels in IFN-treated, VSV-long enough for IFN to be produced. IFN secreted from
the infected cell would then have time to act in an auto- infected PKR2/2 cells indicates that IFN rescues PKR-
deficient cells from cytopathic, productive VSV infectioncrine fashion, inducing other genes required for the es-
tablishment of a complete antiviral state. through mechanisms independent of eIF2a (Figure 4B,
panel b, compare lane 8 to lane 7).To address the role of autocrine IFN produced during
the course of VSV infection, we infected PKR1/1 and To determine whether the observed activation of PKR
and consequent phosphorylation of eIF2a following VSVPKR 2/2 EFs with VSV (moi 5 10) in the presence of
neutralizing anti-IFN-a/b antibodies, which inhibit IFN infection of PKR1/1 EFs would have an inhibitory effect
Immunity
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Figure 4. Activation of PKR and Phosphorylation of eIF2a in PKR1/1 EFs Inhibit VSV mRNA Translation
(A) PKR1/1 (lanes 1±4) and PKR2/2 (lanes 5±8) EFs pretreated with mIFN-a/b (lanes 3, 4, 7, and 8) or left untreated (lanes 1, 2, 5, and 6) were
infected with VSV at an moi of 500 (lanes 2, 4, 6, and 8), or mock-infected (lanes 1, 3, 5, and 7) and labeled with [32P]orthophosphate for 4 hr
in phosphate-free DMEM containing 2% dialyzed FBS. Lysates were prepared from these cells and mPKR was precipitated with poly
(I:C)±agarose, resolved by SDS-PAGE, and visualized by autoradiography.
(B) PKR1/1 and PKR2/2 EFs were treated as above, with the exception that they were incubated in complete DMEM in the absence of
[32P]orthophosphate for 4 hr. Lysates obtained from these cells were subjected to Western blot analysis for mPKR (a), phosphorylated eIF2a
(b), and total eIF2a (c). Tubulin levels (d) show equivalent amounts of protein in each lane. The identities of the individual proteins are indicated
on the right.
(C) PKR1/1 (lanes 1±3) and PKR2/2 (lanes 4±6) either pretreated with mIFN-a/b (lanes 3 and 6) or untreated (lanes 1, 2, 4, and 5) were infected
with VSV at an moi of 10 (lanes 2, 3, 5, and 6) or were mock-infected (lanes 1 and 4). These cells were then labeled with 100 mCi [35S]methionine/
cysteine per ml for 6 hr. Lysates prepared from these cells were immunoprecipitated with anti-VSV antibodies, and VSV proteins were detected
by autoradiography following SDS-PAGE. Identities of individual VSV proteins are shown on the right.
(D) PKR1/1 (lanes 1±3) and PKR2/2 (lanes 4±6) EFs were pretreated (lanes 3 and 6) with mIFN-a/b at 1000 U/ml for 18 hr or were left untreated
(lanes 1, 2, 4, and 5) and subsequently mock-infected (lanes 1 and 4) or infected with VSV (lanes 2, 3, 5, and 6) at an moi of 500. Following
infection, cells were labeled with 50 mCi per ml of [3H]uridine for 6 hr in the presence of 10 mg/ml actinomycin D. RNA was extracted from
lysates prepared from these cells and separated by agarose-urea gel electrophoresis. Viral mRNAs were visualized by fluorography. The
control VSV mRNA sample (lane 7) represents VSV mRNAs obtained from infecting BHK-21 cells with VSV in the presence of [3H]uridine and
actinomycin D and shows the relative sizes of the VSV transcripts. The identities of the individual VSV mRNA species are indicated on the
right.
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on viral protein translation, we followed the synthesis sections of lung tissue from VSV-infected PKR2/2 mice
demonstrated severe edema and congestion of the alve-of VSV proteins by metabolic labeling after infection.
Figure 4C shows that VSV protein synthesis is dramati- oli without any obvious inflammatory cells present in
either the exudate or the alveolar wall (Figure 5B, panelcally increased in PKR2/2 EFs compared to PKR1/1 EFs
(compare lanes 2 and 5). However, IFN pretreatment of d). Interestingly, only lungs from PKR1/1 mice infected
i.n. with VSV showed signs of inflammation, with intersti-PKR2/2 cells was able to reduce VSV protein synthesis
rates to the virtually undetectable levels seen in un- tial pneumonitis, thickening of alveolar walls, and prolif-
eration of pneumocytes (Figure 5B, panel b). This wastreated or IFN-treated wild-type fibroblasts (Figure 4C,
compare lane 6 to lanes 2 and 3). To examine whether accompanied by infiltration of histiocytes, lymphocytes,
and neutrophils. In the absence of viral infection, how-the inhibition of protein synthesis was due to a reduction
in viral mRNA synthesis, PKR1/1 and PKR2/2 cells were ever, no immune system abnormalities were overtly evi-
dent in mice lacking PKR (splenocytes: 26.8% CD41,infected with VSV in the presence of [3H]uridine and
actinomycin D to suppress cellular RNA synthesis. This 12.7% CD81, 50.3% B2201 in PKR2/2 mice versus 26.7%
CD41, 13.5% CD81, 55.7% B2201 in PKR1/1 mice; thy-analysis showed that VSV mRNA synthesis was signifi-
cantly reduced but not ablated in wild-type cells com- mocytes: 9.0% CD41, 2.5% CD81, 86.4% CD4/CD8 dou-
ble-positive in PKR2/2 mice versus 9.5% CD41, 2.6%pared to PKR-deficient cells (Figure 4D, compare lanes
2 and 5). We reason that the reduction in VSV mRNA CD81, 85.8% CD4/CD8 double-positive in PKR1/1 mice;
data not shown). Staining of lung sections from VSV-synthesis in PKR1/1 cells is at least in part due to the
unavailability of viral proteins (as a result of the transla- infected PKR1/1 and PKR2/2 mice for viral proteins using
anti-VSV antibodies clearly showed significant VSV rep-tional block imposed by PKR) for viral genome replica-
tion, which is required for amplification of mRNA tran- lication in the lungs of PKR2/2 mice (Figure 5C). Very
little evidence of VSV antigen was seen in infected lungsscription in VSV-infected cells. Initial transcription from
input genomic templates by the RNA-dependent RNA retrieved from PKR1/1 mice. Curiously, no significant
apoptosis, as determined by TUNEL and caspase acti-polymerase carried within the virion into the cell (Wagner
and Rose, 1996) is likely responsible for the small vation assays, could be detected in the lungs of PKR-
deficient mice infected with VSV for reasons that pres-amount of viral mRNA transcription seen in the PKR1/1
cells. Indeed, analysis of VSV mRNA transcription in ently remain unknown (data not shown). To determine
if prophylactic administration of IFN could protect thePKR1/1 and PKR2/2 cells in the presence of the protein
synthesis inhibitor cycloheximide showed that tran- PKR2/2 mice against lethal VSV infection, 25,000 U of
IFN was administered i.p. as well as i.n. 18 hr priorscription from input genomic templates in PKR1/1 and
PKR2/2 cells were comparable, indicating that viral tran- to VSV infection and 12 and 48 hr postinfection. This
treatment was not able to prevent lethal VSV infection,scription per se is not affected in cells containing PKR
(data not shown). It is noteworthy that IFN-treated cells although it did cause a significant reduction in viral yield
from both the lungs and the brains of PKR-deficientwere also defective in viral mRNA production (Figure
4D). Since there was no increase in the levels of phos- mice (Figure 5D). Since IFN was able to protect PKR2/2
EFs against productive VSV infection in vitro, it is possi-phorylated eIF2a in the IFN-treated PKR2/2 cells follow-
ing VSV infection, the mechanism by which IFN sup- ble that tissues comprising the respiratory tract may be
less responsive to IFN (Ronni et al., 1997).presses viral protein and/or mRNA synthesis in the
absence PKR is likely independent of eIF2a. Given these findings, it was plausible that PKR2/2
mice would be compromised in their immunity to i.n.
infection by other viruses. Therefore, we next examinedSusceptibility of PKR2/2 Mice to Intranasal Infection
the effects of influenza virus infection in PKR-deficientby VSV and Influenza Virus
and wild-type mice. The mouse-adapted influenzaTo determine the importance of PKR antiviral activity
A/WSN/33 strain of the virus was used for this purpose.against VSV infection in vivo, PKR-deficient or geno-
We found that, similar to VSV, WSN did not cause anytype-controlled normal mice were inoculated by differ-
mortality when inoculated i.v. (data not shown). How-ent routes with varying amounts of VSV. Neither intrave-
ever, PKR2/2 mice were significantly more susceptiblenous (i.v.) nor intraperitoneal (i.p.) injections of up to 1 3
to i.n. WSN infection, and all infected mice died at doses106 pfu VSV caused any morbidity in either PKR1/1 or
of 1 3 105 pfu/mouse within 6 days (Figure 6A). In fact,PKR2/2 mice (data not shown). In contrast, intranasal
three out of five PKR2/2 mice succumbed to i.n. infection(i.n.) inoculation of VSV was found to be extremely lethal
with as low as 1 3 104 pfu/mouse, while none of theto PKR2/2 mice but not to wild-type mice (BALB/c,
wild-type mice succumbed to this dose of virus (Figure129terSv, 129terSv 3 BALB/c). In fact, as few as 100
6A). Viral yields obtained from the lungs of infected micepfu VSV killed most of the PKR null mice within 8 days,
showed z7-fold greater levels of WSN in PKR2/2 versusand 1 3 105 pfu VSV proved lethal to all PKR-deficient
PKR1/1 animals (Figure 6D). Interestingly, we also no-animals by day 6 (Figure 5A). These mice displayed
ticed significant apoptosis in the lungs of WSN-infectedmarked respiratory distress and succumbed to paralytic
animals, particularly in PKR-deficient mice. Aside fromdisease. PKR1/1 mice, however, suffered no mortality
prominent TUNEL staining (Figure 6B), the lungs fromand exhibited no overt signs of sickness even after i.n.
WSN-infected PKR2/2 mice had higher levels of bothinfection with 1 3 106 pfu/mouse VSV. Examination of
active caspase 8 and 9 compared to wild-type miceviral loads in the tissues of the infected animals indicated
(Figure 6C), implying that the virus (either inadvertentlythat VSV replicated to high titers primarily in the lungs
or deliberately) activates apoptosis in infected cells dur-and brain of the PKR2/2 mice (Figure 5D).
Histological examination of hematoxylin/eosin-stained ing the course of its replication. WSN infection of EFs
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Figure 5. Mice Lacking PKR Are Very Susceptible to VSV Replication and Lethality
(A) PKR1/1 and PKR2/2 mice were infected i.n. with 1 3 105 pfu VSV or 1 3 102 pfu VSV per mouse with or without prophylactic IFN treatment.
Mice were monitored daily for up to 14 days, and animals surviving at the indicated time points are plotted versus time. Five to six mice per
genotype were used for each condition.
(B) Paraffin-embedded lung sections taken from mock-infected (a and c) or VSV-infected (b and d) PKR1/1 and PKR2/2 mice were stained
with hematoxylin/eosin and photographed at 1003 magnification. Severe edema is evident in VSV-infected PKR2/2 lungs (d), whereas marked
infiltration is seen in similarly infected PKR1/1 cells (c).
(C) PKR1/1 (a) and PKR2/2 (b) lung sections were stained for VSV antigens using a polyclonal antiserum that recognizes all VSV proteins.
Dense staining is present only in the PKR2/2 section.
(D) PKR1/1 and PKR2/2 mice were infected i.n. with 1 3 105 pfu/mouse VSV. Titers from organs were determined 5 days postinfection by
standard plaque assay on BHK-21 cells. Numbers represent the mean titers of duplicate samples from two mice per condition. Individual
titers did not vary by more than one log.
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Figure 6. PKR2/2 Mice Show Increased Susceptibility to Intranasal Infection by WSN
(A) PKR1/1 and PKR2/2 mice were infected i.n. with 1 3 105 pfu or 1 3 104 pfu WSN per mouse. Mice were monitored daily for up to 14 days,
and animals surviving at the indicated time points are plotted versus time. Five to six mice per genotype were used for each condition.
(B) Lung tissue taken from mock infected or WSN-infected PKR1/1 and PKR2/2 mice were assayed for DNA fragmentation by TUNEL, or (C)
analyzed for caspase 8 and 9 activity, as described in Experimental Procedures. Data shown represent the mean of duplicate samples from
two mice per condition.
(D) PKR1/1 and PKR2/2 mice were infected i.n.with 1 3 105 pfu/mouse WSN. Titers from organs were determined 6 days postinfection by
standard plaque assay on MDCK cells in the presence of trypsin. Numbers represent the mean titers of duplicate samples from two mice per
condition. Individual titers did not vary by more than one log.
from PKR2/2 and wild-type mice did not result in signifi- Discussion
cant differences in cytopathicity at all moi's tested (data
A number of studies have indicated that PKR plays a keynot shown), but z10-fold higher virus yields were also
role in IFN-mediated host defense against viral infection.obtained from PKR2/2 EFs than from wild-type EFs (data
However, to date no reports exist to demonstrate innot shown). Collectively, our data demonstrate that PKR
is critical for protection against i.n. infection by VSV and vivo an essential and nonredundant role for PKR in viral
immunity. Here we provide unambiguous evidenceWSN.
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showing that cells and mice devoid of PKR lack defen- the infected animals. Finally, it is further possible that
cell-specific factors may also dictate whether a cell willsive capabilities against VSV at usually nonlethal doses
and show significantly increased sensitivity to influenza undergo apoptosis or not in response to a particular
stimuli. In this regard Sindbis virus vectors carrying pro-virus.
Our data indicate that PKR prevents replication of apoptotic Bax were found to induce accelerated apo-
ptotic death in several cultured cell lines but triggeredVSV in the early stages of the viral replicative cycle,
probably after initial transcription of the viral mRNAs significantly less neuronal apoptosis in vivo compared
to control virus (Lewis et al., 1999). Nevertheless, thatfrom the negative sense RNA genome template by the
RNA-dependent RNA polymerase carried by the virus. VSV induces cytolysis of nearly all malignant cells ana-
lyzed speculatively indicates that PKR function may beIn wild-type cells, PKR was activated following infection
with VSV, an effect that coincided with an increase in affected in these types of cells. It is noteworthy that this
information has recently been exploited by our labora-phosphorylated eIF2a compared to uninfected cells. It is
noteworthy that compared to PKR1/1 fibroblasts, lower tory to demonstrate that VSV can selectively eliminate
a variety of tumors in murine models and may thus bebasal levels of phosphorylated eIF2a were observed in
PKR2/2 fibroblasts, implying that PKR may be a regula- useful as an oncolytic virus in the treatment of cancer
(S. B. and G. B., unpublished data).tor of eIF2a phosphorylation, even in the absence of
viral infection. Other eIF2a kinases such as PERK/PEK Another difference in response to VSV infection in
vitro versus in vivo was observed when IFN pretreatment(Harding et al., 1999; Shi et al., 1998) the murine homolog
of S. cerevisiae, GCN2 (Berlanga et al., 1999), or HRI preceded infection. It was found that priming with IFN-
a/b or -g could effectively compensate for the loss of(Berlanga et al., 1998) may be responsible for the resid-
ual phosphorylated eIF2a observed in PKR2/2 cells. PKR and prevent VSV replication in PKR-deficient fibro-
blasts but not in vivo. Inhibition of viral replication byHowever, since eIF2a phosphorylation did not increase
in PKR2/2 cells compared to wild-type cells following type I and II IFN in EFs occurred without invoking an
apoptotic response and was independent of eIF2aeither transfection of dsRNA or infection with VSV, our
data strongly indicate that PKR is the predominant eIF2a phosphorylation. Although it is not yet clear which IFN-
responsive genes are responsible for compensating forkinase activated following viral infection. In fact, a per-
ceptible decrease in the levels of phosphorylated (but PKR action, it has been shown that fibroblasts and ani-
mals with a defective IFN system (i.e., lacking STAT1 ornot total) eIF2a was observed following VSV infection
of PKR2/2 cells, the reasons for which are unclear. These the IFN-a/b receptor) are extremely sensitive to VSV, as
well as to other types of viral disease (Muller et al.,observations complemented data showing that VSV pro-
tein synthesis occurred to an appreciable degree only 1994; Durbin et al., 1996; Meraz et al., 1996). Since PKR
presumably exists in STAT1-deficient cells and in mostin cells lacking PKR, in which no increase of eIF2a phos-
phorylation was seen. PKR1/1 cells also displayed about cell types in a latent form in the absence of IFN stimula-
tion, other IFN-induced genes besides PKR must be10-fold lower levels of VSV RNA synthesis compared to
PKR2/2 cells, probably because synthesis of viral protein essential for preventing VSV replication. However, our
data indicate that PKR may provide a crucial first line(which is inhibited in wild-type cells) is required for the
amplification of viral mRNA seen in the PKR2/2 cells. of defense against certain types of viral infection by
delaying the production of progeny virions through theThe importance of PKR in preventing VSV infection
was underscored by the fact that mice lacking this ki- inhibition of viral mRNA translation prior to the induction
of IFN. IFN, acting in an autocrine fashion, would thennase are extremely susceptible to lethal i.n. VSV infec-
tion. VSV was shown to replicate to high titers in PKR2/2 induce other genes necessary to fortify the antiviral
state. Indeed, we show in this study that treatment ofprimary EFs, as well as in the lungs and brain of PKR-
deficient mice. Examination of the lungs of VSV-infected wild-type cells with neutralizing anti-IFN antibodies fol-
lowing VSV infection rendered these cells permissive toPKR2/2 mice revealed severe alveolar congestion and
edema. It is therefore likely that in combination with viral replication, even though PKR was present in these
cells. In the absence of PKR's translational block, VSVencephalitis and paralytic disease resulting from viral
replication in the central nervous system, pulmonary presumably replicates to high levels before the induction
of IFN, at which time IFN-induced antiviral host genefailure may have contributed to the death of these mice.
In EFs derived from PKR2/2 mice, VSV infection trig- products may be ineffective. Alternatively, our data di-
rectly indicate that PKR may also function in the actualgered caspase 9±activated apoptosis. It is not yet clear
whether the virus actively triggers apoptosis of the cell induction of IFN itself, possibly by activating NF-kB-
dependent transcription of IFN following viral infection.to enhance its release and systemic dissemination or
whether the induction of apoptosis in the virally infected A number of studies have shown that fibrobasts lacking
either PKR or the b subunit of IkB kinase (IKKb) arecell is a host defense mechanism that prevents estab-
lishment of a persistent infection (Levine et al., 1993; defective in both dsRNA and VSV-mediated induction
of IFN (Yang et al., 1995; Kumar et al., 1997; Chu et al.,Albert et al., 1998). Interestingly, in tissue extracts from
VSV-infected mice, we were unable to detect significant 1999). In addition, phosphorylation of STAT1 on serine
727 and transactivation has also been reported to besigns of apoptosis by assays designed to detect either
DNA fragmentation or activation of various caspases, impaired in PKR null cells (Koromilas et al., 1992; Ra-
mana et al., 2000). Defective STAT1 signaling in PKR2/2indicating that cytolysis as a direct result of viral replica-
tion may possibly be responsible for cell death in vivo. cells would presumably not only impede the production
of STAT1-dependent genes required for the augmen-Alternatively, it is feasible that an analysis of infected
tissue earlier after infection, rather than after 5±7 days as tation of IFN production, such as interferon-regulatory
factor (IRF) 7, but also critical ISGF3-dependent antiviraldescribed here, may yield more evidence of apoptosis in
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genes required for complete protection of the cell (Marie both B cells (to produce sufficient neutralizing antibod-
ies against progeny virions and for antigen presentationet al., 1998). Further, the dependence on both the trans-
to T cells) and eventually T cells, primarily to providelational and transcriptional activities of PKR for the
the assistance that B cells need to switch isotype andtimely and maximal induction of IFN explain why STAT1
maintain a sustained antibody response (Freer et al.,and IFN-a/b-deficient systems are susceptible to virus
1994). These studies demonstrate the exquisitely syner-infection even though PKR is present and why PKR2/2
gistic nature of the acquired and innate immune re-cells and animals are compromised in their defense
sponses in successfully clearing a viral infection.against VSV even though other components of the IFN
Given our findings, it was possible that PKR may besystem are present.
important for preventing the replication of viruses otherWhile IFN was able to rescue PKR2/2 EFs from the
than VSV. As a start to exploring these possibilities, weeffects of VSV, it was unable to protect PKR2/2 mice
show that PKR-deficient animals were about 10- to 100-following i.n. infection with VSV. One explanation for this
fold more sensitive to the lethal effects of i.n. WSN infec-could be that cells comprising the pulmonary tissue are
tion compared to wild-type mice. Although EFs derivednot particularly responsive to IFN, though our prelimi-
from PKR2/2 mice exhibited the same degree of cyto-nary investigations indicate IFN induction per se is not
pathicity compared to EFs from wild-type mice, the for-impaired (data not shown). Although the highest dose
mer cells were approximately ten times more permissiveof IFN used in our experiments might not have been
to WSN replication (data not shown). Viral titers from thesufficient to completely prevent VSV replication, our
lungs of PKR1/1 versus PKR2/2 mice similarly showeddata is supported by recent evidence showing poor IFN-
greater virus progeny yield in the absence of PKR. Unlikea/b production and IFN-induced gene expression in hu-
VSV, WSN infection of mice also induced prominentman alveolar epithelial and fetal lung cells (Ronni et al.,
apoptosis of the infected cells in vivo. We have pre-1997). Only a modest response to IFN can be observed
viously shown a dependence on the FADD/caspase 8in the lungs of VSV-infected PKR2/2 mice, as shown by
death signaling pathway in WSN-infected immortalizeda two-log reduction in viral titers after IFN treatment.
cells undergoing apoptosis that can be potentiated byThat other groups have shown some protective effects
IFN (Balachandran et al., 2000). Since specific caspaseof IFN, when administered i.n. in high doses in mice
inhibitors proved toxic to EFs, we could not further delin-presumably containing PKR, may again indicate a role
eate the mechanisms of cell death in this study. How-for PKR in efficient IFN signaling (Gresser et al., 1975;
ever, we have previously shown that EFs lacking FADDHeremans et al., 1980; Wyde et al., 1984; Ramana et al.,
exhibit resistance to influenza virus-mediated apoptosis,2000).
while VSV required the presence of functional Apaf-1 toIt is further interesting that while STAT1- and IFN-a/b
induce cell death (Balachandran et al., 2000). Influenzareceptor-deficient mice are susceptible to lethal VSV
virus has also been reported by others to regulate Fas-infection irrespective of the route of administration,
dependent apoptosis in vitro (Takizawa et al., 1996). InPKR-deficient mice seem to be compromised in their
the pulmonary tissue of infected mice, however, weimmunity to this virus primarily when it is administered
found that WSN infection induces the activation of bothi.n. but not i.v. Thus, PKR seems to be particularly impor-
caspases 8 and 9, possibly because the activation oftant in preventing productive infection of the respiratory
caspase 8 in vivo causes the recruitment and cleavagetract and functions directly by inhibiting translation and
of Bid, which then induces the efflux of cytochrome cindirectly by recruiting other components of the immune
from the mitochondrion and triggers Apaf-1-dependentsystem to the site of infection (as highlighted by the
activation of caspase 9 (Li et al., 1997; Luo et al., 1998).markedly greater infiltration of leukocytes in lungs from
Influenza virus replication in wild-type mice is usuallyVSV-infected PKR1/1 but not PKR2/2 mice). In light of
restricted to the respiratory tract, a characteristicthese observations, it is noteworthy that pulmonary tis-
thought to be determined, at least in part, by the viral
sue, while relatively refractory to IFN, contains signifi-
hemagglutinin (HA) surface glycoprotein (Klenk and Gar-
cantly higher basal levels of PKR than other tissues
ten, 1994). However, a recent report showed systemic
(Krust et al., 1982). and fulminant influenza infection following i.n. inocula-
While the IFN system (including PKR) is clearly critical tion of WSN in mice lacking STAT1 and IFN-a/b receptor.
in protection against VSV infection, an important role These findings indicate that inhibition of viral replication
for natural neutralizing antibodies, predominantly gener- by IFN may be a major determinant of WSN tissue tro-
ated by peritoneal CD51 B-1 cells, has recently been pism (Garcia-Sastre et al., 1998). Similar to this pheno-
shown (Ochsenbein et al., 1999). These antibodies rep- type, we also found evidence of WSN replication in the
resent a spontaneous repertoire of circulating immuno- spleen and other organs of WSN-infected PKR2/2 mice
globulins that play an important role in preventing patho- but not wild-type mice (data not shown). This increased
gen, including VSV, dissemination to vital organs in the range of tropism may be responsible for the greater
host (Ochsenbein et al., 1999). Mice lacking B cells but sensitivity displayed by the PKR2/2 mice to fatal i.n.
not T cells succumb to lethal VSV infection after i.n. infection by WSN. The fact that WSN is primarily pneu-
inoculation within 1 week (G. N. B. and S. B., unpublished motropic in wild-type animals further strengthens the
data) or after i.v. inoculation, as shown elsewhere argument that the respiratory tract is relatively intransi-
(Thomsen et al., 1997). Thus, mice lacking an ability gent to the antiviral effects of IFN.
to produce antibody, or with a defective IFN response In light of our findings, it is therefore plausible that
pathway, or lacking PKR (as described here) are acutely PKR contributes toward host defense by not only sup-
sensitive to VSV. Thus, the IFN system is not in itself pressing the translation of viral RNAs but also by aug-
menting the production of IFN as well as stimulating thesufficient to prevent VSV infection and likely requires
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fluorometer (Turner Designs, Sunnyvale, CA). The TUNEL assay wasexpression of death receptors such as Fas, employed
performed using the In Situ Cell Death Detection Kit from Boehringerby cytotoxic T cells in destruction of the virally infected
Mannheim (Indianapolis, IN).cell (Balachandran et al., 1998). Besides playing a role
in innate immunity to virus infection, PKR may thus also Acknowledgments
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